Detection of Antimicrobial Resistance

Phenotypic Intro - Resistance Spotting 101

• Phenotypic methods: Detect antimicrobial resistance (AMR) by observing bacterial growth response to antibiotics.
• Core principle: "Sees" if bacteria can grow (resistant) or are inhibited/killed (susceptible) by a drug.
• Directly measures the expressed resistance; what the drug actually encounters in the patient.
• Often considered the reference standard for guiding clinical therapy.
• Major categories:
  • Disk Diffusion (e.g., Kirby-Bauer): Measures zone of inhibition size.
  • Dilution (Broth/Agar): Determines Minimum Inhibitory Concentration (MIC).
  • Automated Systems: Provide rapid, standardized results.
• Pros: Clinically intuitive, generally cost-effective.
• Cons: Slower (requires bacterial growth), some resistance mechanisms (e.g., inducible clindamycin resistance) may require specific tests.

⭐ The Minimum Inhibitory Concentration (MIC) is the lowest concentration of an antimicrobial that inhibits visible growth of a microorganism after overnight incubation; a cornerstone of susceptibility testing.

Diffusion/Dilution - Zone & MIC Workhorses

• Phenotypic methods: Observe growth inhibition by antimicrobials.
• Disk Diffusion (Kirby-Bauer)
  • Principle: Antibiotic diffuses from disk into agar.
  • Measures: Zone of Inhibition (ZOI) diameter (mm).
  • Interpretation: ZOI correlates to S/I/R (CLSI/EUCAST).
  • Qualitative/Semi-quantitative.
  • 
• Dilution Methods (Broth/Agar)
  • Principle: Organism vs. serial antibiotic dilutions.
  • Determines: Minimum Inhibitory Concentration (MIC) - lowest concentration inhibiting visible growth.
  • Quantitative.
  • Broth microdilution: Common (96-well plates).
• MIC: Crucial for therapy; guides dosage.

  ⭐ MIC is the lowest concentration of an antimicrobial that inhibits visible growth of a microorganism in vitro.

• MBC (Minimum Bactericidal Concentration): Lowest concentration killing ≥99.9% of initial inoculum.

Targeted Phenotypic Tests - Superbug Unmasking

• MRSA (Methicillin-Resistant S. aureus)
  • Cefoxitin disc (30µg): Zone ≤ 21mm for S. aureus.
  • PBP2a detection (e.g., latex agglutination, chromogenic agar).
• VRE (Vancomycin-Resistant Enterococci)
  • Vancomycin screen agar (6 µg/ml vancomycin).
• ESBL (Extended-Spectrum β-Lactamase) Producers
  • Screen: Resistance to 3rd gen cephalosporins (e.g., Cefotaxime, Ceftazidime).
  • Confirm: Combination Disc Test (CDT) - Ceftazidime/Cefotaxime ± Clavulanate (zone difference ≥ 5mm).
• AmpC β-Lactamase
  • Cefoxitin resistance.
  • AmpC disc test / Cloxacillin synergy test.
• Carbapenemase Producers (CPE)
  • Screen: Carbapenem resistance (Ertapenem most sensitive indicator).
  • Confirm: mCIM (zone 6-15mm or pinpoint colonies); eCIM for MBLs (zone difference ≥ 5mm with EDTA).

⭐ The mCIM test is crucial for detecting carbapenemase activity, and eCIM helps differentiate Metallo-β-Lactamases (MBLs) using EDTA. This has largely replaced the less specific Modified Hodge Test (MHT).

Genotypic & Novel Methods - Gene Code Crackers

• Genotypic Methods: Directly detect resistance genes or mutations.
  • PCR & Real-time PCR: Rapid; targets specific genes (e.g., mecA, vanA, blaKPC, mcr-1).
  • DNA Microarrays/Multiplex Panels: Simultaneous detection of multiple resistance genes.
  • Whole Genome Sequencing (WGS): Comprehensive; identifies known/novel mechanisms, crucial for outbreak epidemiology.
  • Advantages: Fast (hours), culture-independent, not affected by prior antibiotic use.
  • Limitation: Gene presence ≠ expression of resistance.
• Novel & Rapid Phenotypic Methods:
  • MALDI-TOF MS: Detects antibiotic degradation (e.g., β-lactamase activity by identifying hydrolyzed antibiotic peaks).
  • Bacteriophage-based assays: Use phage lysis or reporter systems for rapid susceptibility.

⭐ Detection of the mecA gene by PCR is a cornerstone for identifying Methicillin-Resistant Staphylococcus aureus (MRSA).

High‑Yield Points - ⚡ Biggest Takeaways

• Phenotypic methods: Kirby-Bauer (disk diffusion) and MIC determination (E-test, dilution) are key.
• Genotypic methods (PCR) detect resistance genes like mecA (MRSA) and vanA (VRE).
• ESBLs detected by double-disk synergy (DDST) or combination disk tests (ceftazidime + clavulanate).
• Carbapenemase detection: Carba NP test (preferred) or Modified Hodge Test (MHT).
• Cefoxitin disk diffusion is the recommended screening for MRSA.
• D-test detects inducible clindamycin resistance in staphylococci (iMLS_B).
• Automated systems (VITEK) provide rapid MICs and resistance profiles.